KETA — TripSitter Clinic Income Statement
0.000.00%
- CA$0.27m
- CA$0.59m
- CA$0.01m
Annual income statement for TripSitter Clinic, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0.087 | 0.488 | 0.014 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 0.179 | 10.3 | 2.36 | 0.319 |
Operating Profit | -0.179 | -10.2 | -1.87 | -0.305 |
Net Income Before Taxes | -0.179 | -10.2 | -1.87 | -0.305 |
Net Income After Taxes | -0.179 | -10.2 | -1.87 | -0.305 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.179 | -10.2 | -1.87 | -0.305 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.179 | -10.2 | -1.87 | -0.305 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.03 | -1.69 | -0.307 | -0.053 |